Thursday, January 26, 2017

UPDATE 1-Biogen's 2017 revenue forecast misses estimates

Jan 26 (Reuters) - Biogen Inc reported quarterly

revenue that missed analysts' estimate, largely due to lower

demand for some of its multiple sclerosis drugs, and forecast

2017 revenue well below...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)